Scientists have discovered that the enzyme BbLDH is crucial for the survival and infectivity of the Lyme disease bacterium ...
Lyme disease, the most common tick-borne illness in the U.S. and Europe, is caused by Borrelia burgdorferi. A new study may ...
Virax Biolabs (VRAX) has started enrolling patients into its United Kingdom based, multi-center clinical study. Conducted in collaboration with ...
Virax Biolabs begins enrolling patients in clinical study assessing T cell dysfunction in post-acute infection syndromes: London Wednesday, March 19, 2025, 16:00 Hrs [IST] Virax B ...
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today ...
A GP has warned those who often find themselves exhausted to watch out for two, red flag signs that could indicate an ...
In Estonia, many people learned a lesson from ethnomedicine as children: that placing a plantain leaf on a scraped knee would ...
Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and most likely other tick-borne diseases as well.
Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, ...
A team of scientists has zeroed in on an enzyme that could revolutionize Lyme disease treatment. By uncovering the crucial ...